OBI Pharma re-elects its board of directors and supervisors, and selects a new chairman of the board.

Taipei, Taiwan – 7 February 2013 – OBI Pharma, Inc. (GreTai Securities Market Code 4174) held its first extraordinary shareholders’ meeting of the year on the morning of 7 February 2013. This was immediately followed by the election of the company’s 4th Board of Directors and Supervisors, amendment of the articles of association, and the […]

This article is password protected.

To view the content, please enter your password in the field below